Vivo Capital as of June 30, 2016
Portfolio Holdings for Vivo Capital
Vivo Capital holds 23 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sagent Pharmaceuticals | 26.6 | $97M | 6.5M | 14.98 | |
| Aclaris Therapeutics (ACRS) | 21.1 | $77M | 4.2M | 18.47 | |
| Eiger Biopharmaceuticals | 8.7 | $32M | 1.6M | 19.82 | |
| Nabriva Therapeutics | 6.5 | $24M | 3.2M | 7.50 | |
| Ascendis Pharma A S (ASND) | 6.4 | $23M | 1.8M | 13.27 | |
| Codexis (CDXS) | 6.1 | $23M | 5.6M | 4.03 | |
| Agile Therapeutics | 4.2 | $15M | 2.0M | 7.61 | |
| Advanced Accelerat spon ads each rep 2 ord | 3.8 | $14M | 456k | 30.23 | |
| Trevena | 3.0 | $11M | 1.7M | 6.30 | |
| Capnia | 2.4 | $8.7M | 7.5M | 1.16 | |
| Aimmune Therapeutics | 2.2 | $8.3M | 763k | 10.82 | |
| Regenxbio Inc equity us cm (RGNX) | 2.2 | $7.9M | 990k | 8.00 | |
| Akari Therapeutics | 1.9 | $7.1M | 528k | 13.49 | |
| Dynavax Technologies (DVAX) | 1.4 | $5.2M | 360k | 14.58 | |
| Pronai Therapeutics | 1.3 | $4.9M | 2.4M | 1.99 | |
| Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.8 | $2.8M | 4.2M | 0.66 | |
| Minerva Neurosciences | 0.6 | $2.0M | 200k | 10.21 | |
| Mei Pharma | 0.4 | $1.5M | 1.1M | 1.36 | |
| Revance Therapeutics | 0.3 | $1.1M | 77k | 13.60 | |
| Ocera Therapeutics | 0.1 | $291k | 153k | 1.90 | |
| Capnia Inc Common Stock Warrants | 0.1 | $245k | 944k | 0.26 | |
| Palatin Technologies | 0.0 | $103k | 235k | 0.44 | |
| Zosano Pharma | 0.0 | $125k | 99k | 1.27 |
